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ABSTRACT
Objective Repetitive interaction with microbial stimuli
renders epithelial cells (ECs) hyporesponsive to microbial
stimulation. Previously, we have reported that buccal ECs
from a subset of paediatric patients with Crohn’s disease
are not hyporesponsive and spontaneously released
chemokines. We now aimed to identify kinetics and
mechanisms of acquisition of hyporesponsiveness to
microbial stimulation using primary human buccal
epithelium.
Design Buccal ECs collected directly after birth and in
later stages of life were investigated. Chemokine release
and regulatory signalling pathways were studied using
primary buccal ECs and the buccal EC line TR146.
Findings were extended to the intestinal mucosa using
murine model systems.
Results Directly after birth, primary human buccal ECs
spontaneously produced the chemokine CXCL-8 and
were responsive to microbial stimuli. Within the ﬁrst
weeks of life, these ECs attained hyporesponsiveness,
associated with inactivation of the NF-κB pathway and
upregulation of the novel NF-κB inhibitor SLPI but no
other known NF-κB inhibitors. SLPI protein was
abundant in the cytoplasm and the nucleus of
hyporesponsive buccal ECs. Knock-down of SLPI in
TR146-buccal ECs induced loss of hyporesponsiveness
with increased NF-κB activation and subsequent
chemokine release. This regulatory mechanism extended
to the intestine, as colonisation of germfree mice elicited
SLPI expression in small intestine and colon. Moreover,
SLPI-deﬁcient mice had increased chemokine expression
in small intestinal and colonic ECs.
Conclusions We identify SLPI as a new player in
acquisition of microbial hyporesponsiveness by buccal
and intestinal epithelium in the ﬁrst weeks after
microbial colonisation.
INTRODUCTION
Mucosal epithelial cells (ECs) are equipped with
pattern recognition receptors (PRR), such as toll-
like receptors (TLR) and nucleotide-binding oligo-
merisation domain-containing (NOD) receptors1
that incite cellular activation after ligation of spe-
ciﬁc bacterial structures.2 In healthy individuals, the
interaction with commensal intestinal microbiota
does not lead to an ensuing inﬂammatory response.
However, upon encounter of pathogenic bacteria,
PRRs convey the proinﬂammatory immune
responses that are required to eradicate these
pathogens.3 The mechanisms that account for this
tailored hyporesponsiveness of ECs are a topic of
extensive research.4 Using murine models it has
been shown that ECs of neonatal mice become
Signiﬁcance of this study
What is already known on this subject?
▸ In healthy individuals, the mucosal epithelium
is hyporesponsive (tolerant) towards the
commensal microﬂora.
▸ In patients with Crohn’s disease and ulcerative
colitis, aberrant epithelial responses to
commensal microbiota contribute to chronic
inﬂammation of the gastrointestinal tract.
▸ Buccal epithelium from a subset of paediatric
patients with Crohn’s disease, spontaneously
released increased amounts of CXCL-8, CXCL-9
and CXCL-10 when compared to epithelium
from healthy controls and children with
ulcerative colitis.
What are the new ﬁndings?
▸ Neonatal buccal epithelial cells (ECs) are
immunologically active and respond to
microbial stimuli.
▸ Within the ﬁrst weeks of life, buccal EC acquire
hyporesponsiveness.
▸ SLPI drives buccal EC hyporesponsiveness
through regulation of NF-κB signalling.
▸ SLPI also regulates EC hyporesponsiveness to
microbiota in the intestine.
How might it impact on clinical practice in
the foreseeable future?
▸ Future research will identify whether activity of
buccal epithelium may serve as a biomarker to
identify a particular subset of patients with
Crohn’s disease who have speciﬁc alterations in
innate immune regulation.
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hyporesponsive to TLR stimulation immediately after birth.5 6
The acquisition of this hyporesponsiveness was dependent on a
transient cellular activation induced by contact with exogenous
TLR ligands.6 Transient epithelial stimulation was found to
induce a negative regulatory mechanism through depleting IL-1
receptor associated kinase-1 (IRAK-1) which rendered the cells
unresponsive to subsequent stimulation.5 6
Acquisition of microbial hyporesponsiveness is seen in several
innate cell types and can be regulated via multiple mechanisms.
Functional experiments with epithelial and monocytic cells have
shown that PRR signalling can be controlled by reducing the
surface expression of the receptors or inhibition of mRNA syn-
thesis.7 Additionally, a network of intracellular negative regula-
tors can limit PRR-mediated overactivation. Among these, IL-1
receptor-associated kinase M (IRAK-M), NOD2, Tollip, A20,
Single Immunoglobulin Interleukin-1 Receptor-related protein
(SIGIRR) and SLPI have been found to inhibit intracellular
signal transduction at various stages during the signalling
cascade; ultimately leading to reduced NF-κB activation and
inﬂammatory gene expression.8–13
Currently, it is unclear how human primary ECs acquire
microbial hyporesponsiveness. In patients with Crohn’s disease
and ulcerative colitis aberrant epithelial responses to commensal
microbiota contribute to chronic inﬂammation of the gastro-
intestinal tract.14 Recently, we have observed that buccal ECs
from paediatric patients with Crohn’s disease spontaneously
released increased amounts of CXCL-8, CXCL-9, and
CXCL-10 when compared to epithelium from healthy controls
and children with ulcerative colitis.15 Stimulation with bacterial
products resulted in a further increase of chemokine production
by buccal ECs from paediatric patients with Crohn’s disease,
whereas the epithelium of healthy controls and patients with
ulcerative colitis remained hyporesponsive to TLR stimulation.
These data reveal that primary buccal ECs are a valuable tool to
study acquisition of hyporesponsiveness in human primary epi-
thelium, and may help identify dysregulation of this mechanism
in Crohn’s disease.
The aim of this study was to address how primary buccal ECs
from healthy individuals have become hyporesponsive to TLR
stimulation as a result of microbial colonisation of the intestinal
tract. It is likely that the transition from the sterile in utero
environment to continuous contact with microbial products at
birth is a pivotal event for shaping epithelial responses.
Therefore, we investigated the chemokine release and microbial
responsiveness of human buccal ECs directly after birth and in
later stages of life, and studied EC responses during colonisation
of germ-free mice.
METHODS
Buccal EC collection
Buccal ECs were collected from at-term neonates and controls
(ages indicated in ﬁgure legends). For neonates, the cells were
obtained within 10 min after birth. The buccal ECs were col-
lected by gently rubbing the inside of the cheeks with a
Cytobrush Plus (CooperSurgical, Trumbull, Connecticut, USA).
Buccal EC suspensions were washed twice in phosphate buffered
saline (PBS) and centrifuged for 5 min at 485 g. Buccal ECs con-
taminated with blood detectable by microscopy were excluded
from further analyses. Written informed consent was obtained
from each donor or, when applicable, from the parents. The
local ethics committee has approved the study protocol (also see
online supplementary methods).
Cell culture and stimulation assays
LPS and PG stimulation of buccal ECs
Buccal ECs (3.5×104) from neonates or controls were seeded in
200 μl medium per well of a 96-wells ﬂat bottom plate
(Corning B.V. Life Sciences, Amsterdam, The Netherlands).
Buccal ECs were left untreated or were stimulated with either
lipopolysaccharide (LPS) (1 μg/mL) or peptidoglycan (PG)
(10 μg/mL) for 24 h, and supernatants were collected for
enzyme linked immunosorbent assay (ELISA). The remaining
buccal ECs were used for cytospin analysis or intracellular
protein analysis. Cellular viability before and after culture
was determined by trypan blue staining, neutral red assay and
[3-(4,5- Q11dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium, inner salt] (MTS) assay. To
obtain cytospins, cells were resuspended in 50 μl PBS and 50 μl
10% human serum albumin, and spun onto microscope slides at
50 g. The slides were air dried on silica gel, and either used
directly for immunohistochemical staining or stored at −20°C.
Desensitisation of TR146 cells
TR146 cells (kindly provided by Professor Mark Herzberg,
University of Minnesota, USA), used at passages ranging from 3
to 15, were seeded at a density of 0.5×105 cells/mL in a 24-well
plate (Corning B.V. Life Sciences) and cultured for 24 h, after
which the cells were stimulated with PG (50 μg/mL) for 24 h or
left untreated. Supernatant was collected for ELISA. For resti-
mulation, the cells were washed and restimulated with PG
(50 μg/mL) or medium and incubated for another 24 h, after
which the supernatant was collected for ELISA. For measure-
ments of NF-κB activation, TR146 cells (0.5×106 cells/mL)
were stimulated with PG (50 μg/mL) for 24 h or left untreated.
Supernatant was collected for ELISA and cells were collected
for analysis of intracellular protein. The remainder of the cells
was restimulated with PG for 5, 15 or 45 min, and nuclear and
cytosolar cell fractions were analysed.
Statistical analysis
Statistical analysis was performed using unpaired or paired t
test, t test with Welch correction, Mann–Whitney analysis, and
two-way ANOVA, as indicated in the ﬁgure legends. Calculated
p values are indicated in the ﬁgures.
RESULTS
Neonatal buccal ECs spontaneously produce CXCL-8 and are
highly responsive to microbial stimuli
To investigate whether primary ECs from neonates are respon-
sive to microbial stimuli, we collected buccal ECs from 14 new-
borns within 10 min after birth and compared their activation
status with ECs from 15 controls aged 2–6 months. Neonatal
buccal ECs spontaneously released substantial amounts of
CXCL-8 when compared to ECs from controls (ﬁgure 1A).
After 24 h of culture, buccal ECs were viable and actively
responded to bacterial stimulation, as demonstrated by the add-
itional increase in chemokine release upon incubation with LPS
or PG (ﬁgure 1A; see online supplementary ﬁgure 1).
Responsiveness to bacterial stimulation was restricted to neo-
natal buccal ECs, since neither control infant buccal ECs
(2–6 month) nor buccal ECs from adults (age 29–55 years) were
responsive to bacterial stimulation (ﬁgure 1A; see online supple-
mentary ﬁgure 1). Adult buccal ECs were viable and not
anergic, as shown in online supplementary ﬁgure 1.
At birth, a transition occurs from the sterile in utero environ-
ment in amniotic ﬂuid to an environment rich in microbial
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products. As such, chemokine release by the epithelium directly
after birth may be a remnant of activation by components in the
amniotic ﬂuid which were encountered in utero. Indeed, pre-
natal CXCL-8 production by intestinal ECs has been
observed.16 Alternatively, the epithelium is inactive at birth and
only starts releasing chemokines after microbial encounter
during birth. Therefore, we assessed if 6 h preincubation with
amniotic ﬂuid alone could induce CXCL-8 production by
buccal ECs from adult subjects (age 29–55 years) after 24 h of
culture. Amniotic ﬂuid incubation did not evoke CXCL-8
production (ﬁgure 1B), nor did preincubation prime sensitivity
to a subsequent stimulation with Pam3Cys (ﬁgure 1B). These
data strengthen the hypothesis that ﬁrst microbial contact at
birth initiates a temporary activation of the epithelium.
Vaginal birth is associated with ECs coming into contact with
a higher number and a larger variety of microbial stimuli than
birth by caesarean section. Therefore, the effect of the method
of delivery on epithelial responsiveness was assessed.
Spontaneous CXCL-8 release by buccal ECs from neonates
delivered through vaginal birth was equal to or higher than that
Figure 1 Neonatal buccal epithelial cells (ECs) spontaneously produce CXCL-8 and are highly responsive to microbial stimuli. (A) Buccal ECs from
14 neonates and 15 controls aged 2–6 months were collected and cultured for 24 h with or without LPS (1 μg/mL) or PG (10 μg/mL), and CXCL-8
release was measured by ELISA. Data are expressed as means with SEM. p Values calculated using a Mann–Whitney analysis. (B) Buccal ECs from
11 controls (age 29–55 years) were collected and incubated for 6 h with or without (–) amniotic ﬂuid (AF). After washing, cells were cultured with
or without Pam3Cys (Pam, 10 μg/mL) for 24 h and CXCL-8 release was determined. As a control, buccal ECs from 3 neonates were incubated for
24 h with or without Pam3Cys. Data are expressed as means with SEM. p Values calculated using a Mann–Whitney analysis. (C) Buccal ECs were
collected from neonates born via vaginal birth (n=10) or born by caesarean section (n=4). Buccal ECs from 15 subjects (age 2–6 months) served as
control. Cells were cultured for 24 h with or without stimulus and CXCL-8 was determined in the supernatant. Cellular viability assessed by trypan
blue staining and neutral red assay was not affected by 24 h in culture. Data are expressed as means with SEM. p Values calculated using a Mann–
Whitney analysis. (D) CXCL-8 stain (brown, top) or isotype control (bottom) on cytospins of neonatal buccal ECs. Staining is representative for 3
different donors. (E) Buccal ECs from 3 neonates delivered by caesarean section were collected at several time points after birth. Buccal ECs of
neonate 1 were collected on days 4, 11 and 21. Buccal ECs for neonate 2 were collected on days 3 and 20, and buccal ECs for neonate 3 were
collected on days 4 and 12. Cells were stimulated with LPS (1 μg/mL) for 24 h. CXCL-8 production was measured in supernatant.
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from neonates delivered by caesarean section (ﬁgure 1C).
Immunohistochemical staining conﬁrmed that CXCL-8 was pro-
duced by ECs (ﬁgure 1D). To establish the kinetics with which
primary buccal epithelium from neonates loses microbial
responsiveness, buccal ECs from three neonates delivered by
caesarean section were collected at several time points after
birth and stimulated with LPS. CXCL-8 production was reduced
over time in all three neonates (ﬁgure 1E). Overall, these data
show that primary buccal ECs obtained directly after birth
secrete chemokines, and are responsive to bacterial stimulation,
whereas infant and adult buccal ECs have lost this capacity.
Priming of naive TR146 cells with peptidoglycan results in
hyporesponsiveness that is associated with the expression
of SLPI
As primary epithelium is short-lived, we wished to identify a
putative mechanism for acquisition of epithelial hyporesponsive-
ness using the buccal epithelial cell line TR146. Cell lines that
are initially responsive to microbial stimuli have been shown to
progressively become hyporesponsive to prolonged LPS stimula-
tion.17 Indeed, TR146 cells incubated for 24 h with PG released
substantial amounts of CXCL-8 (ﬁgure 2A). This release was
largely inhibited when the cells were pretreated with the same
concentration of PG for 24 h (ﬁgure 2A). To identify whether
hyporesponsiveness was accompanied by reduced NF-κB activ-
ity, phosphorylated NF-κB levels were measured in nuclear frac-
tions as well as total and phosphorylated IκB levels in cytosolic
fractions. TR146 cells stimulated once with PG showed a clear
increase in nuclear phosphorylated NF-κB levels compared to
hyporesponsive TR146 cells, indicating a more activated pheno-
type of the former cells (ﬁgure 2B). In contrast to cells which
ﬁrst encountered PG, hyporesponsive TR146 cells preincubated
with PG for 24 h and subsequently restimulated with PG for 0,
5, 15 and 45 min showed no increase in nuclear translocation of
NF-κB, no reduction in cytosolic IκB levels, and contained
lower levels of phosphorylated IκB (ﬁgure 2B).
To assess the factors involved in downregulation of the NF-κB
pathway, we ﬁrst searched for known negative regulatory mole-
cules in hyporesponsive TR146 cells. Recently, we established
that SLPI is a mucosal immune regulator for microbial sensitiv-
ity by dendritic cells.18 Therefore, we cultured TR146 cells with
or without stimulus and analysed changes in SLPI expression
and protein production. Indeed TR146 cells expressed SLPI
mRNA, spontaneously released SLPI protein in the supernatant
and, upon stimulation with PG, increased their SLPI release
(ﬁgure 2C, D). SLPI can act as a potent inhibitor of TLR stimu-
lation in three ways. First, SLPI can directly interact with LPS,
thus inhibiting TLR-mediated activation in responder cells.19
Second, intracellular SLPI can inhibit toll-like receptors 2 and 4
signalling by direct prevention of the degradation of the inhibi-
tory factor IκBα.20 Third, SLPI can act in the nucleus by directly
binding to an NF-κB p65 consensus sequence in the promoter
region of the CXCL-8 and TNF-α genes, thus blocking tran-
scription.11 To assess whether SLPI could also perform its intra-
cellular inhibitory functions, we determined the SLPI
concentration in cytosol and nuclear fractions and found that
SLPI protein could be detected in the cytosol and the nucleus of
TR146 cells (see online supplementary ﬁgure 2).
To determine the relative contribution of the inhibitory role
of SLPI in hyporesponsive TR146 cells to that of other inhibi-
tors, we compared SLPI mRNA expression to that of other
known inhibitors involved in downregulation of the NF-κB
pathway. Very low levels of A20, Tollip or SIGIRR mRNA could
be found in the lysates of TR146 cells by PCR analysis while
SLPI mRNA was abundantly present and could be enhanced by
microbial stimulation (ﬁgure 2E).
The acquisition of hyporesponsiveness and subsequent SLPI
expression were not restricted to buccal ECs only, as cells from
the colonic EC line, Caco-2, responded similarly (see online
supplementary ﬁgure 3). These data indicate that hyporespon-
sive ECs exhibit higher levels of IκB and lower levels of phos-
phorylated NF-κB and phosphorylated IκB which correlated
with increased production of SLPI protein.
Knockdown of SLPI in the buccal epithelial cell line, TR146,
results in spontaneous high CXCL-8 production
To elucidate the role for SLPI in acquisition of hyporesponsive-
ness and loss of CXCL-8 production, endogenous SLPI was
knocked down using stable shRNA expression in TR146 cells.
Mock transduced cells which received the pRSC retroviral
vector only, and cells which were transduced with a non-
silencing sequence were used as controls. Knockdown of SLPI in
the TR146 cells was successful, as demonstrated by reduced
SLPI mRNA levels and SLPI secretion (ﬁgure 3A, B). Crucially,
knockdown of SLPI led to spontaneously enhanced production
of CXCL-8 in the knockdown cells at mRNA and protein levels
when compared with mock transduced cells (ﬁgure 3A, B). SLPI
knockdown also spontaneously increased CXCL-9 mRNA and
CXCL-10 protein production in SLPI knockdown cells (see
online supplementary ﬁgure 2). These data demonstrate that
inhibition of SLPI abrogates cellular hyporesponsiveness and
leads to increased chemokine production.
Neonatal buccal epithelial cell sensitivity to microbial
stimulation is associated with decreased SLPI expression
We then examined whether hyporesponsive adult buccal ECs
had a phenotypic proﬁle that was similar to hyporesponsive
TR146 cells. In agreement with the TR146 data, lysates of
responsive neonatal buccal ECs had lower levels of IκBα than
adult hyporesponsive buccal ECs (ﬁgure 4A). Upon analysis of
six adult donors, intracellular SLPI was consistently detectable
in whole cell lysates (ﬁgure 4B). Based on the TR146 experi-
ments described above, we hypothesised that SLPI is involved in
acquiring hyporesponsiveness, and therefore wished to deter-
mine whether neonatal cells expressed low levels of SLPI. In the
buccal cavity, SLPI is present as a secretory product of the saliv-
ary gland.21 In theory, buccal ECs could take up SLPI from their
environment. Therefore, we determined the presence of SLPI
mRNA in neonatal and adult buccal ECs. Hyporesponsive adult
buccal ECs expressed signiﬁcantly higher levels of SLPI mRNA
compared to responsive neonatal buccal ECs (ﬁgure 4C). In
comparison, mRNA levels for A20, Tollip and SIGIRR were
very low or undetectable in neonatal and adult buccal ECs
(ﬁgure 4D).
As SLPI has been shown to exert its immunosuppressive activ-
ities at different cellular sites, we further analysed the cellular
location of SLPI protein in buccal ECs from adults. Crucially,
SLPI was found abundantly in the nuclear fraction (ﬁgure 4E,
F) of adult buccal ECs. As expected, SLPI was also located
within the cytosolic fraction of adult ECs (ﬁgure 4F). On mul-
tiple occasions, cytosolic SLPI was not detected by western blot
analysis (ﬁgure 4E), since the detection limit of this assay was
approximately 25 ng as assessed with recombinant SLPI.
In summary, hyporesponsive buccal ECs from adult indivi-
duals exhibit high levels of IκB compared with responsive neo-
natal buccal ECs. Moreover, adult buccal ECs produce high
levels of SLPI mRNA, whereas expression is low in neonatal
buccal ECs.
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SLPI regulates acquisition and maintenance of
hyporesponsiveness in intestinal epithelium.
Since TR146 ECs and Caco-2 ECs acquired an SLPI-driven
hyporesponsive state after continued exposure to TLR2 stimula-
tion, we reasoned that the epithelium throughout the gastro-
intestinal tract may use similar mechanisms to acquire a
hyporesponsive state. Therefore, we ﬁrst examined the
induction of SLPI expression and the mouse homologue of
CXCL-8 (CXCL-2) in the intestine of adult germ-free mice
which were colonised with conventional microﬂora over time.22
Comparitive transcriptome analyses were performed on small
intestinal and colonic tissue of germ-free and conventionalised
mice sacriﬁced on day 0, day 4 and day 30 after colonisation.
Samples were also collected for immunohistochemical analysis.
Figure 2 Priming of naive TR146 cells
with peptidoglycan results in
hyporesponsiveness that is associated
with the expression of SLPI. (A) TR146
cells were cultured in triplicate for 24 h
with or without peptidoglycan (PG,
50 μg/mL), supernatant was collected
and the cells were washed. Next, the
cells were restimulated with or without
PG (50 μg/mL) for 24 h. CXCL-8
production was determined in the
supernatant at t=24 h and at t=48 h.
Data are means with SEM (n=3).
p Values were calculated using an
unpaired t test. Data are representative
of 3 independent experiments.
(B) TR146 cells were cultured in
duplicate for 24 h with or without PG
(50 μg/mL). A proportion of the cells
was collected after 24 h of culture, and
the remaining cells were then stimulated
with PG for 5, 15 and 45 minutes.
Phosphorylated NF-κB protein bands
were analysed by western blot in the
nuclear fractions of cellular lysates.
Within the cytosolic fraction of cellular
lysates, total IκBα protein bands and
phosphorylated IκBα protein bands
were analysed by western blot.
Densitometry of the bands was used to
determine NF-κB and IκBα levels
relative to ORC2 (nuclear) or β-actin
(cytosolic), and these were expressed as
arbitary units (AU). At t=0 min, AU were
set at 0. Data are representative of two
independent experiments. (C) TR146
cells were stimulated in duplicate for
24 h with PG (50 μg/mL) or left
unstimulated, and cells were harvested
for SLPI mRNA analysis by quantitative
SYBR Green PCR. Data are expressed as
means with SEM. p Values were
calculated using an unpaired t test.
(D) TR146 cells were cultured in
triplicate for 24 h with or without PG
(50 μg/mL). Supernatant was collected
for detection of SLPI protein using
ELISA. Data are representative of four
independent experiments and expressed
as means with SEM (n=3). p Values
were calculated using an unpaired t test.
(E) TR146 buccal epithelial cells were
cultured with 50 μg/mL peptidoglycan
(PG) or without stimulus for 24 h, after
which cellular lysates from duplicate
wells were analysed for A20, Tollip,
SIGIRR and SLPI mRNA expression by
quantitative SYBR Green PCR. Data are
expressed as means with SEM. p Values
were calculated using an unpaired t test.
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In the small intestine, SLPI gene expression was slightly higher
at day 30 of colonisation compared to day 0 (ﬁgure 5A). In the
colon, induction of SLPI gene expression was more pronounced
and signiﬁcantly increased on day 4 after conventionalisation,
and expression remained high on day 30 (ﬁgure 5A). In agree-
ment, immunohistochemistry revealed abundant SLPI protein in
colonic epithelium at day 4 and day 30 of colonisation
(ﬁgure 5B). In the small intestine, SLPI protein was less
abundant than in the colon. These data argue that bacterial
colonisation induces increased SLPI expression in the intestine.
To assess a possible correlation between SLPI expression and
epithelial hyporesponsiveness CXCL-2 expression was deter-
mined. Although CXCL-2 gene expression was signiﬁcantly
increased on day 4 after conventionalisation in small intestine
and colon, the expression returned to germ-free level on day 30
in the colon and tended to decrease in the small intestinal ileum
(ﬁgure 5A, B). Collectively, these data show that colonisation of
the colon results in increased SLPI and CXCL-2 expression at
day 4. However, during extended colonisation, an inverse
relationship between SLPI and CXCL-2 expression developed.
To formally demonstrate that SLPI expression is needed for
inhibition of chemokine release by intestinal ECs in vivo, we
examined CXCL-2 and CXCL-9 expression in freshly isolated
intestinal ECs of normally (SPF) colonised SLPI-deﬁcient mice.
Indeed, small intestinal ECs of SLPI-deﬁcient mice expressed
signiﬁcantly higher mRNA levels of CXCL-2 and CXCL-9
compared to SLPI-sufﬁcient mice (ﬁgure 6). In colonic epithe-
lium of SLPI-deﬁcient mice, the increase of CXCL-2 and
CXCL-9 mRNA showed the same trend but did not reach signiﬁ-
cance, however, immunohistochemistry conﬁrmed increased
CXCL-2 protein levels in colonic ECs of SLPI-deﬁcient animals
(ﬁgure 6).
DISCUSSION
In this study, we have shown that primary buccal ECs secrete
CXCL-8 at birth, and that this secretion is enhanced in response
to microbial triggering. In the ﬁrst weeks of life, ECs actively
acquired hyporesponsiveness to microbial stimulation.
Hyporesponsiveness of ECs corresponded with a decrease in
IκB degradation and a subsequent decrease in NF-κB activation,
and also with an upregulation of SLPI. We show that SLPI is a
crucial mediator for acquisition of epithelial hyporesponsive-
ness, as knockdown of SLPI expression in buccal ECs resulted
in increased CXCL-8 production. This function of SLPI was
shared between buccal epithelium and colonic epithelium, as
colonisation of the intestine of germ-free mice induced persist-
ent upregulation of SLPI expression in small intestinal and
colonic epithelium after introduction of the microbiota. Upon
extended colonisation, this upregulation of SLPI was associated
with decreased CXCL-2 production by colonic epithelium.
Furthermore, small intestinal and colonic ECs of SLPI-deﬁcient
mice spontaneously exhibited enhanced CXCL-2 mRNA expres-
sion compared with SLPI-sufﬁcient mice.
Using human primary buccal ECs, we show that the transition
from the sterile in utero environment to initial and persistent
contact with microbial products after birth is a pivotal event in
shaping human epithelial responses. Within minutes after birth,
buccal ECs from neonates were found to release CXCL-8 which
was increased by microbial triggering. This epithelial responsive-
ness to bacterial stimulation is not restricted to the buccal cavity,
as several groups have shown responsiveness of neonatal intes-
tinal epithelium to pathogen-associated molecular patterns
(PAMPs).6 23 24 The accessibility of the buccal epithelium
allowed us to follow epithelial cell function in the ﬁrst weeks of
life within individual subjects. Despite variation in initial
Figure 3 Knockdown of SLPI in the buccal epithelial cell line TR146 results in spontaneous high CXCL-8 production. (A) TR146 cells were
transduced with virus supernatant containing an empty vector (mock), shRNA for a non-silencing control and shRNA speciﬁc for SLPI. The
transduced TR146 cells were cultured in the presence of 1 μg/mL puromycin for 14 days. After stable culture for 21 days the cells were collected for
SLPI and CXCL-8 mRNA analysis by quantitative SYBR Green PCR. Data are expressed as means (n=2). (B) TR146 cells were cultured for 24 h
without stimulus, SLPI and CXCL-8 protein in supernatant was detected by ELISA. Data are expressed as means with SEM (n=3). p Values were
calculated using an unpaired t test.
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responsiveness, buccal ECs of primary caesarean section-
delivered neonates gradually acquired microbial hyporesponsive-
ness within the ﬁrst 3 weeks of life. In analogy, it was previously
shown in a murine model that the ﬁrst encounter to endotoxin
postpartum elicits chemokine production by intestinal epithe-
lium.6 However, 24 h after birth the exposure to exogenous LPS
had rendered the murine intestinal ECs unresponsive towards
endotoxin. In our study, primary buccal ECs acquired
hyporesponsiveness within a minimum of a few days after birth,
indicating that a responsive period precedes the tolerant state of
buccal ECs found in healthy individuals. Hyporesponsiveness of
adult buccal ECs was not due to death or anergy, as buccal ECs
were viable and showed calcium ﬂuxes (see online supplemen-
tary ﬁgure 1). Moreover, TLR2 mRNA expression was found to
be similar or higher in hyporesponsive adult buccal ECs com-
pared to neonatal buccal ECs (see online supplementary ﬁgure
Figure 4 Neonatal buccal epithelial cell sensitivity to microbial stimulation is associated with decreased SLPI expression. (A) Buccal epithelial cells
(EC) from controls (age 29–55 years) and neonates were collected, lysed and analysed by western blot for IκBα and β-actin proteins. Densitometry
of IκBα protein bands was used to determine IκBα levels. Levels were corrected for β-actin and denoted as arbitary units (AU). p Values were
calculated using unpaired sample t test with Welch correction. (B) Buccal ECs from 6 controls (ages 29–55 years) were collected, and SLPI
expression was assessed by ELISA in whole cell lysate. (C) Buccal ECs from controls (n=5, age 29–55 years) and neonates (n=4, age <24 h) were
collected and directly lysed for analysis of SLPI mRNA expression. Data are expressed as means with SEM. p Values were calculated using an
unpaired t test. (D) Buccal ECs from 4 controls (ages 29–55 years) and 4 neonates (aged less than a day old) were analysed for A20, Tollip, SIGIRR
and SLPI mRNA expression by quantitative SYBR Green PCR. Data are expressed as means with SEM. p Values were calculated using an unpaired t
test. (E) Buccal ECs from controls (age 29–55 years) were collected and incubated without stimulus for 24 h. Cells were lysed, nuclear and cytosolic
fractions isolated, and western blot was performed to detect SLPI protein. (F) Buccal ECs from controls (age 29–55 years) were collected and
incubated without stimulus for 24 h. Afterwards cells were lysed, nuclear and cytosolic fractions isolated, and SLPI protein was detected by ELISA.
n.d. denotes non-detectable.
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1). Therefore, although we cannot fully rule out that reduced
TLR surface expression or subcellular localisation plays a role in
buccal ECs hyporesponsiveness, we explored whether repetitive
exposure of naive ECs to microbial ligands leads to the
production of proteins that regulate the NF-κB pathway. Active
induction of hyporesponsiveness to microbial stimulation has
been described in multiple intestinal cell lines.17 Indeed, cells
from the buccal epithelial cell line TR146 as well as the colonic
Figure 5 Colonisation of the intestine of germ-free (GF) mice results in increased SLPI and CXCL-2 expression in the colon. C57BL/6 mice were
bred under GF conditions and colonised with conventional microbiota. Mice were sacriﬁced on day 0, day 4 and day 30 after conventionalisation,
and samples of jejunum, ileum and colon were taken for mRNA microarray analysis or embedded in parafﬁn for immunohistochemical analysis.
(A) SLPI and CXCL-2 gene expression in intestinal segments of conventionalised mice. Dot plots represent the expression levels of SLPI and CXCL-2
in the intestinal tissues. p Values were calculated using a Mann–Whitney analysis; n=4–11 for each time-point. (B) Immunohistochemical SLPI and
CXCL-2 staining on parafﬁn embedded sections of intestinal tissue from conventionalised mice. Data are representative of three mice. Scale bar
indicates a magniﬁcation of 40×.
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epithelial cell line Caco-2 pretreated for 24 h with a TLR ligand
showed decreased CXCL-8 production in response to restimula-
tion with the same ligand. Hyporesponsiveness of the ECs was
associated with reduced NF-κB activation. However, the Caco-2
cells which had become hyporesponsive to Pam3Cys were still
able to respond to high-dose IL-1β stimulation to the same
extent as responsive cells, indicating that the cells were not
defective in NF-κB signalling (data not shown). Using this
model system we searched for molecular pathways that are
involved in the hyporesponsiveness of ECs. Microbial-associated
molecular patterns are known to have the capacity to induce
regulatory molecules. As such, IRAK-M, NOD2, Tollip, A20,
SIGIRR and SLPI have been found to inhibit intracellular signal
transduction at various stages during the signalling cascade,
ultimately leading to reduced NF-κB activation and inﬂammatory
gene expression.8–13 In our experiments, we identiﬁed that
microbial hyporesponsiveness in TR146, Caco-2 cells and
primary adult buccal ECs were associated with upregulated SLPI
mRNA expression and SLPI protein, while other regulatory
molecules were expressed at low levels or were undetectable.
Subsequent knockdown of SLPI in the TR146 cells revealed that
SLPI constitutively suppresses CXCL-8, CXCL-9 and CXCL-10
production in buccal ECs. It should be noted that in contrast
with human buccal ECs, fresh murine adult and neonatal cheek
epithelium releases substantial amounts of chemokines at
baseline. However, the epithelium is hyporesponsive to a further
stimulation with microbial PG. SLPI did not mediate this hypore-
sponsiveness (see online supplementary ﬁgure 4). As high levels
of the NF-κB inhibitor Tollip are expressed by murine cheek epi-
thelium, we anticipate that Tollip is the major NF-κB regulator
maintaining homeostasis in murine cheek epithelium (see online
supplementary ﬁgure 4).
SLPI is a potent inhibitor of the NF-κB pathway that inter-
feres with microbial-induced TLR activation at multiple levels.
In particular, the secretory form of SLPI can directly interact
with LPS before the latter molecule interacts with responder
cells.19 Intracellular SLPI can inhibit Toll-like receptor 2 and 4
signalling by directly preventing the degradation of the inhibi-
tory factor IκBα.20 Additionally, Taggart et al demonstrated that
SLPI translocates to the nucleus directly binding to the NF-κB
consensus sequence in the promoter region of the CXCL-8 and
TNF-α genes.11 In particular, when incubating monocytic U937
cells or peripheral blood monocytes for 1 h with exogenous
labelled SLPI, the labelled protein could be found in the cytosol
and nucleus of these cells.11 SLPI bound to wild-type biotiny-
lated NF-κB consensus oligonucleotide in a dose-dependent
manner.11 A single base change in the biotinylated consensus
sequence of NF-κB rendered SLPI unable to bind.11 As such,
SLPI may compete with the NF-κB p65 subunit for binding to
this consensus sequence, thus blocking transcription. In TR146
Figure 6 CXCL-2 and CXCL-9 expression is spontaneously enhanced in the intestinal epithelium of SLPI-deﬁcient mice compared to WT mice.
(A) C57BL/6 WT and SLPI-deﬁcient mice were sacriﬁced and small intestinal and colonic epithelial cells were isolated for mRNA analysis. CXCL-2 and
CXCL-9 mRNA expression was assessed by quantitative SYBR Green PCR. Data are representative of two independent experiments. Data are
expressed as mean with SEM (n=4 mice per group). p Values were calculated using an unpaired t test for the CXCL-2 data, and a Mann–Whitney
analysis for the CXCL-9 data. (B) C57BL/6 WT and SLPI-deﬁcient mice were sacriﬁced, and distal colon was embedded in parafﬁn and stained for
CXCL-2 by immunohistochemistry. Data are representative of four C57Bl/6 and four SLPI-deﬁcient mice.
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cells, at least the latter two of these mechanisms play a role in
SLPI-mediated epithelial unresponsiveness. As such, in hypore-
sponsive cells, cytoplasmic levels of IκB were enhanced in the
presence of SLPI (ﬁgure 2B), and nuclear SLPI could clearly be
detected (see online supplementary ﬁgure 2).
In view of its potent function in TR146 cells, SLPI expression
was also investigated in primary buccal ECs. Strikingly, hypore-
sponsive primary buccal ECs of adult individuals expressed sig-
niﬁcantly higher levels of SLPI mRNA compared to responsive
neonatal buccal ECs. Furthermore, in hyporesponsive buccal
ECs, SLPI protein was not only found in the cytosol, but was
also detectable in the nucleus at very high concentrations.
Future study is required to assess whether, through its nuclear
localisation, SLPI inhibits inﬂammation directly by binding the
NF-κΒ consensus sequence in the promoter region of the
CXCL-8 gene.11 Although SLPI is a known regulator of the
NF-κB pathway, its role in driving EC hyporesponsiveness has
been underscored. Besides high expression of SLPI in mucosal
ECs, it is also produced in mucosal secretions such as saliva and
tears. As such, it has potent antiprotease activity providing a
ﬁrst barrier of protection against microbial proteases.25
In previous work, we demonstrated that buccal ECs of paedi-
atric patients with Crohn’s disease without oral lesions are
responsive to microbial stimuli, while healthy controls were
hyporesponsive.15 This raises the question whether a particular
mechanism accounts for the loss of hyporesponsiveness in the
epithelium of paediatric patients with Crohn’s disease. Recently,
in murine experiments SLPI was implicated in recovery from
colonic inﬂammation.26 Here, we have shown that SLPI sup-
presses chemokine production in buccal and intestinal epithe-
lium. Within the intestine, the inhibitory role of SLPI in
regulating the epithelium is evident in the small intestine and
colon. In the small intestine, SLPI expression was more domin-
antly detected in cells in the lamina propria, whereas in the
colon, SLPI expression was most evident within the epithelium.
SLPI-deﬁcient mice exhibited spontaneous CXCL-2 expression
by intestinal epithelium, however, this did not lead to the devel-
opment of colitis in these mice. Our data show that SLPI is a
crucial mediator in the acquisition and maintenance of epithelial
hyporesponsiveness by directly limiting NF-κB activation.
Therefore, these results warrant further study to unravel the
possible role of altered SLPI-mediated NF-κB inhibition in
chronic inﬂammation in the intestine.
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